We compared the data of patients with anti-NMDAR encephalitis, anti-leucine-rich glioma inactivated 1 (anti-LGI1) encephalitis (20), multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) (21–23), and public healthy controls. The gene discussed is LGI1; the disease is neuromyelitis optica.